| __timestamp | Gilead Sciences, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 3788000000 | 17293000 |
| Thursday, January 1, 2015 | 4006000000 | 26470000 |
| Friday, January 1, 2016 | 4261000000 | 28307000 |
| Sunday, January 1, 2017 | 4371000000 | 30354000 |
| Monday, January 1, 2018 | 4853000000 | 32160000 |
| Tuesday, January 1, 2019 | 4675000000 | 37571000 |
| Wednesday, January 1, 2020 | 4572000000 | 39951000 |
| Friday, January 1, 2021 | 6601000000 | 50159000 |
| Saturday, January 1, 2022 | 5657000000 | 54577000 |
| Sunday, January 1, 2023 | 6498000000 | 61940000 |
| Monday, January 1, 2024 | 28675800000 |
Unleashing the power of data
In the competitive landscape of biotechnology, understanding cost efficiency is crucial. Gilead Sciences, Inc. and Vericel Corporation, two prominent players, showcase contrasting cost of revenue trends from 2014 to 2023. Gilead Sciences, with its expansive operations, saw its cost of revenue grow by approximately 72% over the decade, peaking in 2021. This reflects its strategic investments and scaling efforts. In contrast, Vericel Corporation, a smaller entity, experienced a 258% increase, indicating rapid growth and possibly higher operational costs relative to its size. By 2023, Gilead's cost of revenue was nearly 100 times that of Vericel, highlighting the scale difference. These insights underscore the diverse strategies and challenges faced by biotech firms in managing operational costs while pursuing innovation.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Vericel Corporation
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Mesoblast Limited
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Bio-Techne Corporation vs Vericel Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.